Published March 25, 2026 | Version v1
Journal article Open

Digital Health Products and Their Regulatory Challenges

  • 1. YSPM's YTC Faculty of Pharmacy, Satara

Description

ABSTRACT

Mobile health applications, wearable devices, telehealth platforms, artificial intelligence (AI) applications, and electronic health records have changed healthcare delivery through improving access, efficiency, and participation of patients. Regulatory affairs will have an essential part in assuring the safety, effectiveness, quality, and data security of digital health innovations as they expand and grow fast. By influencing how we classify products, evaluate risk, clinically validate, secure cybersecurity, improve interoperability, and evaluate post-market regulatory pathways, we seek to find a balance between innovation and patient safety.

Keywords: Artificial Intelligence (AI), Mobile Health, Quality Assurance

Files

AJPHR143002.pdf

Files (690.0 kB)

Name Size Download all
md5:03a7d4b283c7544802e597d304dc9db3
690.0 kB Preview Download

Additional details

Identifiers

EISSN
2321-3647

Related works

Is published in
Journal article: 2321-3647 (EISSN)

Dates

Available
2026-03-25

References

  • American Journal Of Pharmacy And Health Research